Association Between Phosphate Disturbances and Mortality Among Critically Ill Patients with Sepsis or Septic Shock

Overview

Journal BMC Pharmacol Toxicol

Publisher Biomed Central

Specialty Pharmacology

Date 2021 May 29

PMID 34049590

Citations 17

Authors

Shmeylan A Al Harbi

Hasan M Al-Dorzi

Albatool M Al Meshari

Hani Tamim

Sheryl Ann I Abdukahil

Musharaf Sadat

Yaseen Arabi

Affiliations

Soon will be listed here.

Abstract

Objective: The aim of this study is to examine the association of hypophosphatemia and hyperphosphatemia on the first day of ICU admission with mortality in septic critically ill patients.

Methods: In this retrospective cohort study, all adult patients who were admitted to the medical-surgical ICUs between 2014 and 2017 with sepsis or septic shock were categorized as having hypophosphatemia, normophosphatemia and hyperphosphatemia based on day 1 serum phosphate values. We compared the clinical characteristics and outcomes between the three groups. We used multivariate analysis to examine the association of hypophosphatemia and hyperphosphatemia with these outcomes.

Results: Of the 1422 patients enrolled in the study, 188 (13%) had hypophosphatemia, 865 (61%) normophosphatemia and 369 (26%) had hyperphosphatemia. The patients in the hyperphosphatemia group had significantly lower GCS, higher APACHE II scores, higher serum creatinine, increased use of vasopressors, and required more mechanical ventilation with lower PaO2/FiO2 ratio compared with the other two groups. In addition, the hyperphosphatemia group showed significantly higher ICU and hospital mortality in comparison with the other two groups.

Conclusion: Hyperphosphatemia and not hypophosphatemia on the first ICU admission day was associated with an increase in the ICU and hospital mortality in septic critically ill patients.

Citing Articles

Effect of changes trajectory of serum phosphate levels on the 28-day mortality risk in patients with sepsis: a retrospective cohort study from the MIMIC-IV database.

Zhang R, Zhou D BMC Infect Dis. 2025; 25(1):245.

PMID: 39984839 PMC: 11844063. DOI: 10.1186/s12879-025-10547-9.

Challenging management dogma where evidence is non-existent, weak, or outdated: part II.

Hofmaenner D, Singer M Intensive Care Med. 2024; 50(11):1804-1813.

PMID: 39320462 DOI: 10.1007/s00134-024-07634-x.

The association between serum phosphate and length of hospital stay and all-cause mortality in adult patients: a cross-sectional study.

Zhou Y, Zhang S, Chen Z, Zhang X, Feng Y, Xu R Nutr J. 2024; 23(1):81.

PMID: 39026252 PMC: 11256428. DOI: 10.1186/s12937-024-00982-w.

Hyperphosphatemia in Chronic Kidney Disease: The Search for New Treatment Paradigms and the Role of Tenapanor.

Cernaro V, Longhitano E, Casuscelli C, Peritore L, Santoro D Int J Nephrol Renovasc Dis. 2024; 17:151-161.

PMID: 38831770 PMC: 11144652. DOI: 10.2147/IJNRD.S385826.

Association of serum phosphate and changes in serum phosphate with 28-day mortality in septic shock from MIMIC-IV database.

Nan W, Huang Q, Wan J, Peng Z Sci Rep. 2023; 13(1):21869.

PMID: 38072848 PMC: 10711004. DOI: 10.1038/s41598-023-49170-6.

References

Singer M, Deutschman C, Seymour C, Shankar-Hari M, Annane D, Bauer M . The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016; 315(8):801-10. PMC: 4968574. DOI: 10.1001/jama.2016.0287. View

Bech A, Blans M, Raaijmakers M, Mulkens C, Telting D, de Boer H . Hypophosphatemia on the intensive care unit: individualized phosphate replacement based on serum levels and distribution volume. J Crit Care. 2013; 28(5):838-43. DOI: 10.1016/j.jcrc.2013.03.002. View

Barak V, Schwartz A, Kalickman I, NISMAN B, Gurman G, Shoenfeld Y . Prevalence of hypophosphatemia in sepsis and infection: the role of cytokines. Am J Med. 1998; 104(1):40-7. DOI: 10.1016/s0002-9343(97)00275-1. View

Musher D, Rueda A, Kaka A, Mapara S . The association between pneumococcal pneumonia and acute cardiac events. Clin Infect Dis. 2007; 45(2):158-65. DOI: 10.1086/518849. View

Haider D, Lindner G, Wolzt M, Ahmad S, Sauter T, Leichtle A . Hyperphosphatemia Is an Independent Risk Factor for Mortality in Critically Ill Patients: Results from a Cross-Sectional Study. PLoS One. 2015; 10(8):e0133426. PMC: 4529074. DOI: 10.1371/journal.pone.0133426. View

Arabi Y, Alshimemeri A, Taher S . Weekend and weeknight admissions have the same outcome of weekday admissions to an intensive care unit with onsite intensivist coverage. Crit Care Med. 2006; 34(3):605-11. DOI: 10.1097/01.ccm.0000203947.60552.dd. View

Salem R, Tray K . Hepatic resection-related hypophosphatemia is of renal origin as manifested by isolated hyperphosphaturia. Ann Surg. 2005; 241(2):343-8. PMC: 1356921. DOI: 10.1097/01.sla.0000152093.43468.c0. View

Vervloet M, van Ballegooijen A . Prevention and treatment of hyperphosphatemia in chronic kidney disease. Kidney Int. 2018; 93(5):1060-1072. DOI: 10.1016/j.kint.2017.11.036. View

Zazzo J, Troche G, Ruel P, Maintenant J . High incidence of hypophosphatemia in surgical intensive care patients: efficacy of phosphorus therapy on myocardial function. Intensive Care Med. 1995; 21(10):826-31. DOI: 10.1007/BF01700966. View

10.

Brotfain E, Schwartz A, Boniel A, Koyfman L, Boyko M, Kutz R . Clinical outcome of critically ill patients with thrombocytopenia and hypophosphatemia in the early stage of sepsis. Anaesthesiol Intensive Ther. 2016; 48(5):294-299. DOI: 10.5603/AIT.a2016.0053. View

11.

Berger M, Rothen C, Cavadini C, Chiolero R . Exudative mineral losses after serious burns: a clue to the alterations of magnesium and phosphate metabolism. Am J Clin Nutr. 1997; 65(5):1473-81. DOI: 10.1093/ajcn/65.5.1473. View

12.

Alsumrain M, Jawad S, Imran N, Riar S, DeBari V, Adelman M . Association of hypophosphatemia with failure-to-wean from mechanical ventilation. Ann Clin Lab Sci. 2010; 40(2):144-8. View

13.

Suzuki S, Egi M, Schneider A, Bellomo R, Hart G, Hegarty C . Hypophosphatemia in critically ill patients. J Crit Care. 2012; 28(4):536.e9-19. DOI: 10.1016/j.jcrc.2012.10.011. View

14.

Boot R, Koekkoek K, van Zanten A . Refeeding syndrome: relevance for the critically ill patient. Curr Opin Crit Care. 2018; 24(4):235-240. DOI: 10.1097/MCC.0000000000000514. View

15.

Geerse D, Bindels A, Kuiper M, Roos A, Spronk P, Schultz M . Treatment of hypophosphatemia in the intensive care unit: a review. Crit Care. 2010; 14(4):R147. PMC: 2945130. DOI: 10.1186/cc9215. View

16.

Daily W, Tonnesen A, Allen S . Hypophosphatemia--incidence, etiology, and prevention in the trauma patient. Crit Care Med. 1990; 18(11):1210-4. DOI: 10.1097/00003246-199011000-00004. View

17.

Lim C, Tan H, Kaushik M . Hypophosphatemia in critically ill patients with acute kidney injury treated with hemodialysis is associated with adverse events. Clin Kidney J. 2017; 10(3):341-347. PMC: 5466083. DOI: 10.1093/ckj/sfw120. View

18.

Talakoub R, Bahrami M, Honarmand A, Abbasi S, Gerami H . The Predicting Ability of Serum Phosphorus to Assess the Duration of Mechanical Ventilation in Critically Ill Patients. Adv Biomed Res. 2017; 6:51. PMC: 5433651. DOI: 10.4103/2277-9175.205192. View

19.

Knaus W, Draper E, Wagner D, Zimmerman J . APACHE II: a severity of disease classification system. Crit Care Med. 1985; 13(10):818-29. View

20.

Zhao Y, Li Z, Shi Y, Cao G, Meng F, Zhu W . Effect of hypophosphatemia on the withdrawal of mechanical ventilation in patients with acute exacerbations of chronic obstructive pulmonary disease. Biomed Rep. 2016; 4(4):413-416. PMC: 4812158. DOI: 10.3892/br.2016.605. View